ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,632Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 387

$1.31M Total Retail Price of All Prescriptions

Rank: 16 out of 387

1,007 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 1,007 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 1,007 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 21,698 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,424 934 S3 1 1
LISINOPRIL 1,144 960 2 3
ATENOLOL 831 769 3 20
FUROSEMIDE 798 688 4 7
AMLODIPINE BESYLATE 794 721 5 6
LEVOTHYROXINE SODIUM 791 716 6 2
CITALOPRAM HBR 778 643 7 19
ZOLPIDEM TARTRATE 626 494 8 16
OMEPRAZOLE 538 457 9 4
METOPROLOL TARTRATE 538 485 9 11
TRAMADOL HCL 515 412 11 14
METFORMIN HCL 477 372 12 8
LOSARTAN POTASSIUM 454 420 13 24
HYDROCHLOROTHIAZIDE 419 371 14 12
LOVASTATIN 406 372 15 36
WARFARIN SODIUM 399 345 16 17
POTASSIUM CHLORIDE 387 315 17 9
GLYBURIDE 377 342 R 18 58
ATORVASTATIN CALCIUM 354 319 19 13
SIMVASTATIN 350 302 20 5
FLUTICASONE PROPIONATE 283 252 21 29
CARVEDILOL 281 241 22 21
METOPROLOL SUCCINATE 264 238 23 18
PRAVASTATIN SODIUM 259 224 24 15
CLOPIDOGREL 253 210 25 25
DOXAZOSIN MESYLATE 251 251 26 75
DIOVAN 219 191 27 33
TAMSULOSIN HCL 213 201 28 32
MELOXICAM 202 173 29 22
CYCLOBENZAPRINE HCL 193 61 R 30 42
SERTRALINE HCL 188 148 31 23
DIGOXIN 185 178 32 40
PLAVIX 182 154 33 39
NEXIUM 180 131 34 26
CYMBALTA 178 138 35 44
ADVAIR DISKUS 164 130 36 41
GABAPENTIN 163 125 37 10
ALLOPURINOL 159 151 38 28
PREMARIN 143 129 R 39 77
AMLODIPINE BESYLATE-BENAZEPRIL 139 131 40 54
JANUVIA 139 113 40 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 113 42 30
SYNTHROID 137 131 43 68
TRAZODONE HCL 136 87 44 37
VERAPAMIL ER 134 119 45 87
RANITIDINE HCL 130 103 46 45
FELODIPINE ER 129 129 47 130
DOXYCYCLINE HYCLATE 120 101 48 114
CARISOPRODOL 120 16 R 48 53
CEPHALEXIN 119 110 50 135
CRESTOR 117 93 51 34
PROAIR HFA 115 90 52 47
DONEPEZIL HCL 112 112 53 27
SPIRIVA 111 99 54 61
ESTRADIOL 110 75 R 55 105
AZITHROMYCIN 108 96 56 49
TRIAMTERENE-HCTZ 107 90 57 55
PANTOPRAZOLE SODIUM 106 55 58 48
FAMOTIDINE 102 94 59 78
PREDNISONE 102 63 59 43
FLUOXETINE HCL 97 62 61 46
AMIODARONE HCL 97 81 61 156
LANTUS SOLOSTAR 95 50 63 102
LANSOPRAZOLE 95 80 63 141
KLOR-CON M20 92 63 65 76
AMITRIPTYLINE HCL 88 69 R 66 62
CIPROFLOXACIN HCL 88 71 66 56
LANTUS 87 71 68 51
PAROXETINE HCL 83 83 69 52
OXYCODONE HCL 80 29 S2 70 71
DILTIAZEM 24HR CD 78 78 71 118
FENTANYL 78 34 S2 71 80
SINGULAIR 78 56 71 83
ESCITALOPRAM OXALATE 76 52 74 73
CLONIDINE HCL 72 62 75 38
OXYBUTYNIN CHLORIDE ER 72 53 75 120
ATENOLOL-CHLORTHALIDONE 72 51 75 328
ALENDRONATE SODIUM 72 62 75 31
GEMFIBROZIL 71 53 79 93
LACTULOSE 71 45 79 153
ROPINIROLE HCL 71 71 79 91
PROPRANOLOL HCL 70 36 82 100
PROMETHAZINE HCL 69 42 R 83 82
GLIPIZIDE 68 67 84 63
VENTOLIN HFA 66 59 85 142
NABUMETONE 65 40 86 117
CLOTRIMAZOLE-BETAMETHASONE 64 57 87 206
VENLAFAXINE HCL ER 63 50 88 97
TRIAMCINOLONE ACETONIDE 63 51 88 159
NAMENDA 63 63 88 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 51 91 90
KLOR-CON 10 60 57 92 124
MORPHINE SULFATE ER 60 13 S2 92 79
ENALAPRIL MALEATE 58 46 94 69
CELEBREX 57 56 95 72
PEN NEEDLE 57 30 95 173
LIPITOR 57 51 95 103
METHYLPREDNISOLONE 56 51 98 101
TERAZOSIN HCL 56 56 98 109
ISOSORBIDE MONONITRATE ER 56 41 98 59
TIZANIDINE HCL 56 14 98 127
OXYBUTYNIN CHLORIDE 56 42 98 134
ACIPHEX 55 53 103 261
RAMIPRIL 53 27 104 119
GENERLAC 53 30 104 272
DILTIAZEM ER 53 49 104 139
INSULIN SYRINGE 52 46 107 151
BACLOFEN 52 17 107 154
PHENYTOIN SODIUM EXTENDED 51 51 109 107
TEKTURNA 50 50 110 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.